Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1436-3305
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study ; day:11 ; month:1 ; year:2020 ; pages:1-12
Gastric cancer ; (11.1.2020), 1-12
- Urheber
-
Dijksterhuis, Willemieke P. M.
Verhoeven, Rob H. A.
Meijer, Sybren L.
Slingerland, Marije
Haj Mohammad, Nadia
de Vos-Geelen, Judith
Beerepoot, Laurens V.
van Voorthuizen, Theo
Creemers, Geert-Jan
van Oijen, Martijn G. H.
van Laarhoven, Hanneke W. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10120-020-01039-7
- URN
-
urn:nbn:de:101:1-2020041812260413517725
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dijksterhuis, Willemieke P. M.
- Verhoeven, Rob H. A.
- Meijer, Sybren L.
- Slingerland, Marije
- Haj Mohammad, Nadia
- de Vos-Geelen, Judith
- Beerepoot, Laurens V.
- van Voorthuizen, Theo
- Creemers, Geert-Jan
- van Oijen, Martijn G. H.
- van Laarhoven, Hanneke W. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma : Past, present and future
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma : Past, present and future
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Risk factors for gastroesophageal reflux disease: a population-based study
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study